To further determine whether Ror2 effects on cell invasion were mediated through MMP2, RCC cells seeded in matrigel-coated Boyden chambers were treated with 60 uM cis-9-Octadecenoyl-N-hydroxylamide (an MMP2 inhibitor) or vehicle. Here, ROR2 is linked to renal cell carcinoma.